Your browser doesn't support javascript.
loading
Novel t(5;11)(q32;q13.4) with NUMA1-PDGFRB fusion in a myeloid neoplasm with eosinophilia with response to imatinib mesylate.
Zou, Ying S; Hoppman, Nicole L; Singh, Zeba N; Sawhney, Sameer; Kotiah, Sandy D; Baer, Maria R.
Afiliação
  • Zou YS; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD.
  • Hoppman NL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
  • Singh ZN; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD.
  • Sawhney S; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD.
  • Kotiah SD; Mercy Medical Center, Baltimore, MD.
  • Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD. Electronic address: mbaer@umm.edu.
Cancer Genet ; 212-213: 38-44, 2017 04.
Article em En | MEDLINE | ID: mdl-28449810

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor beta de Fator de Crescimento Derivado de Plaquetas / Antígenos Nucleares / Proteínas Associadas à Matriz Nuclear / Eosinofilia / Mesilato de Imatinib / Transtornos Mieloproliferativos Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Cancer Genet Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Moldávia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor beta de Fator de Crescimento Derivado de Plaquetas / Antígenos Nucleares / Proteínas Associadas à Matriz Nuclear / Eosinofilia / Mesilato de Imatinib / Transtornos Mieloproliferativos Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Cancer Genet Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Moldávia